Plasmid-Mediated Colistin Resistance in Salmonella enterica : A Review
Tiago Lima, Sara Domingues, Gabriela Jorge Da Silva
Microorganisms · 2019
doi:10.3390/microorganisms7020055 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Colistin is widely used in food-animal production. <i>Salmonella enterica</i> is a zoonotic pathogen, which can pass from animal to human microbiota through the consumption of contaminated food, and cause disease, often severe, especially in young children, elderly and immunocompromised individuals. Recently, plasmid-mediated colistin resistance was recognised; <i>mcr</i>-like genes are being identified worldwide. Colistin is not an antibiotic used to treat <i>Salmonella</i> infections, but has been increasingly used as one of the last treatment options for carbapenem resistant Enterobacteria in human infections. The finding of mobilizable <i>mcr</i>-like genes became a global concern due to the possibility of horizontal transfer of the plasmid that often carry resistance determinants to beta-lactams and/or quinolones. An understanding of the origin and dissemination of <i>mcr</i>-like genes in zoonotic pathogens such as <i>S. enterica</i> will facilitate the management of colistin use and target interventions to prevent further spread. The main objective of this review was to collect epidemiological data about mobilized colistin resistance in <i>S. enterica</i>, describing the <i>mcr</i> variants, identified serovars, origin of the isolate, country and other resistance genes located in the same genetic platform.
Abstract licence: CC BY
Cited by papers we hold4
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.